No statistically significant correlations were found between the expression of E-cadherin and vimentin in tumor budding areas and the invasive component and galectin-3 immunoreactivity in bladder urothelial carcinoma. The gene discussed is LGALS3; the disease is bladder transitional cell carcinoma.